Celltrion Skincure, the specialized cosmetics division of global biotechnology pioneer Celltrion, has continuously innovated the high-performance skincare sector by leveraging world-class pharmaceutical biotechnology.

The company achieved substantial industry acclaim with the launch of ZIPIDERM, an advanced bio-derma cosmetic brand powered by 'Celltrion Bio EGF™'—a proprietary high-purity, high-activity recombinant epidermal growth factor developed by Celltrion's Biotechnology Research Institute.

Utilizing a multi-layered nano-carrier system of approximately 150nm, ZIPIDERM boosts transdermal absorption by over 170% compared to conventional formulations. Its signature hero products, the 'Skin Barrier Intensive Cream' and 'Hydro Ampoule', achieved immediate sell-outs upon launching at Olive Young and successfully expanded into nationwide pharmacy distribution via the Baropharm platform as well as North American markets through Amazon.

Consumers seeking bio-derma solutions demand significantly higher clinical rigor than mainstream skincare shoppers. Facing acute challenges such as post-procedure barrier disruption, severe dehydration, and hyper-sensitive redness, these users require empirical, quantifiable evidence of actual barrier recovery rather than generic marketing claims.

Relying solely on subjective verbal consultations made it difficult to communicate the unique molecular efficacy of Bio EGF across omnichannel touchpoints and recommend personalized routines tailored to individual skin barrier conditions.

To visually demonstrate ZIPIDERM's biomedical efficacy at the consumer point of contact and provide precision skincare matchmaking, Celltrion Skincure implemented becon's AI Precision Skin Analysis Solution.

■ High-Precision Skin Barrier Diagnostics via becon IoT Scanner: At offline pop-ups, flagship counseling zones, and partnered clinics and pharmacies, clients undergo precision skin examinations using the becon IoT scanner. The device evaluates critical dermatological metrics including epidermal moisture, sebum secretion, pore dimension, erythema (sensitivity), pigmentation, and elasticity. Invisible microscopic barrier damage and underlying hydration imbalances are clearly visualized through high-resolution AI diagnostic reports.

■ Tailored 1:1 Bio-Derma Prescriptions & Algorithmic Product Matchmaking: Grounded in real-time diagnostic data, specialists prescribe personalized ZIPIDERM regimens calibrated to each client's specific barrier impairment level. For severely damaged skin barriers, the 'Skin Barrier Intensive Cream' is recommended; for compromised moisture cores, the 'Hydro Ampoule' and 'Milky Toner' are paired together. This science-backed process transforms subjective advice into an authoritative, data-driven shopping experience.

■ Visual Before-and-After Verification of Bio-Efficacy: By rescanning the skin following product usage, becon provides direct before-and-after comparative reports measuring barrier restoration, redness alleviation, and moisture retention. Providing irrefutable, visual proof that Celltrion's Bio EGF fundamentally repairs compromised skin barriers cultivates profound brand loyalty and sustained reorders.

Key Results of becon AI Implementation

■ Empirical Proof of Bio-Tech Efficacy: Replacing conventional sales narratives with objective AI diagnostic metrics and before-and-after visual proof established ZIPIDERM as an authentic, clinically proven bio-derma authority.

■ Accelerated Purchasing Decisions & Basket Size (ATV) Expansion: Clear visualization of skin barrier damage prompted rapid, confident buying decisions and spurred multi-product purchases (pairing intensive creams with barrier ampoules and toners), substantially elevating Average Transaction Value (ATV).

■ Strengthened Omnichannel & Medical-Beauty Competitiveness: Standardizing an advanced AI diagnostic protocol across pharmacies, medical aesthetic clinics (ZIPIDERM EX), and retail counters delivered a sophisticated, future-ready K-Bio Beauty consultation journey for domestic and global consumers alike.